IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 37.41% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 73.24M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 49.93.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.
Overvalued
The company’s latest PE is 43.49, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.12M shares, decreasing 7.79% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 559.40K shares of this stock.